Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects

NCT07277933 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: KHN702
DRUG: KHN702 placebo

Sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd.